Abstract:Background:The intestine is now known as a key metabolic organ that is involved in the development of metabolic complications in obesity and diabetes.Studies on obese and insulin resistant rodents and humans show that small intestine develops a local insulin resistance state, an altered lipid and lipoprotein metabolism, low-grade inflammation and increased paracellular permeability.Because of the complex microenvironment surrounding intestinal epithelial cells, it is not clear so far whether intestinal dyshomeostasis is primarily induced by exogenous obesity-related factors or is a response to obesity-related endogenous alterations in the host.Objectives: To assess the impact of obesity-related endogenous factors (i.e.hyperglycemia, dyslipidemia, inflammation or endocannabinoid system activation) on intestinal epithelial functions in organoids.Methods: Organoids, derived from male C57BL/ 6 mouse duodenum, were incubated 24h with the following conditions: a) inflammatory state (20 mM LPS, 100 nM TNF a, IL-1b and IFNg); b) dyslipidemia (5 mM vs. 2 mM of Palmitate:Oleate [2:1] in 1 mM BSA); c) hyperglycemia (2600 mg/L vs. 1000 mg/L); and d) endocannabinoid system activators(ACEA and Noladin).Results: Incubation of organoids with insulin (30 min, EC50=10 nM) induced a dose-response activation of Akt Ser473 phosphorylation.Insulin signaling was blunted by the induction of an inflammatory state (-50%, p<0.05) and by free fatty acid levels similar to dyslipidemia (-37%, p<0.05) while hyperglycemia only reduce insulin sensitivity at much higher glucose levels than observed in diseases [>4500 mg/L].These obesity-related endogenous factors also impact the expression of several genes related to the epithelial cell functions in the intestine.The inflammatory state increase expression of genes related to intestinal paracellular permeability ( Tjp, Ocln, Marveld2), immune and inflammatory response (Def20, Muc1, Lyz2, Tnf), lipid and lipoprotein metabolism (Mttp, Dgat1/2, Acss2, Acaca) and nutrient transport (Slc2a2/5, Slc5a1, Abcg5/8, Fabp2).Endocannabinoid system activation also led to several changes in the expression of genes related to intestinal paracellular permeability ( Tjp, Marveld2), immune and inflammatory response (Def20, Lyz2, Muc2, Tnf), lipid and lipoprotein metabolism (Mttp, Dgat1, Fabp2) and glucose homeostasis (Gip, Slc2a2/5, Slc5a1) but with divergent effects according to the ligands (ACEA vs. Noladin).Conclusion: This study demonstrates that basolateral exposure of small intestine epithelium organoids to obesity-related factors impact the ability of the cell to signal insulin and suggest the development of alterations in other key intestinal functions.Overall, this study suggests that the host metabolic states may represent an important mechanism in the development of small intestine alteration in obesity.

Db130035 3736..3746

Overnutrition stimulates intestinal epithelium proliferation through β-catenin signaling in obese mice.

Conditional deletion of β-catenin in the mediobasal hypothalamus impairs adaptive energy expenditure in response to high fat diet and exacerbates diet-induced obesity

Tu1206 EFFECT OF BACILLUS SUBTILIS AND ENTEROCOCCUS FAECALIS SUPERNATANT ON SERT EXPRESSION IN ENTEROCYTES AND RAT INTESTINAL TISSUES

Wnt/β-catenin Signaling in Osteoblasts Regulates Global Energy Metabolism.

Metabolic Crosstalk: Molecular Links Between Glycogen and Lipid Metabolism in Obesity

The Baf60c/Deptor pathway links skeletal muscle inflammation to glucose homeostasis in obesity.

Wnt/β-Catenin Signaling and Obesity

Obesity-Induced Regulator of Calcineurin 1 Overexpression Leads to Β-Cell Failure Through Mitophagy Pathway Inhibition

CTNNB1/β-catenin Dysfunction Contributes to Adiposity by Regulating the Cross-Talk of Mature Adipocytes and Preadipocytes.

A multi-omics approach to overeating and inactivity-induced muscle atrophy in db/db mice

Deficiency of intestinal Bmal1 prevents obesity induced by high-fat feeding

A protein kinase C α and β inhibitor blunts hyperphagia to halt renal function decline and reduces adiposity in a rat model of obesity-driven type 2 diabetes

Dietary Intervention Reprograms Bone Marrow Cellular Signaling in Obese Mice.

[Molecular Mechanism of SH2B1 in Regulating JAK2/IRS2 During Obesity Development].

Activation of Gs signaling in mouse enteroendocrine K-cells greatly improves obesity- and diabetes-related metabolic deficits

Gut microbiota-bile acids-glucagon like peptide-1 axis contributes the resistance to high fat diet-induced obesity in mice

Impaired Adiponectin Signaling Contributes to Disturbed Catabolism of Branched-Chain Amino Acids in Diabetic Mice

C-Abl Inhibition Mitigates Diet-Induced Obesity Through Improving Insulin Sensitivity of Subcutaneous Fat in Mice

Characterization of Signaling Pathways Associated with Pancreatic β-cell Adaptive Flexibility in Compensation of Obesity-linked Diabetes in db/db Mice

Cannabinoid CB1 Receptor Deletion from Catecholaminergic Neurons Protects from Diet-Induced Obesity